Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.08%487.59M | -11.04%130.87M | -15.58%114.38M | 4.30%116.39M | 34.29%125.96M | 41.33%487.96M | 47.27%147.11M | 62.85%135.49M | 31.77%111.6M | 12.53%93.79M |
| Cost of revenue | 10.33%418.08M | 0.34%115.14M | 0.87%103M | 10.59%97.08M | 42.75%102.86M | 19.22%378.93M | 25.54%114.75M | 33.22%102.1M | 6.21%87.79M | -2.46%72.06M |
| Gross profit | -36.25%69.51M | -51.39%15.73M | -65.90%11.38M | -18.90%19.31M | 6.25%23.09M | 297.57%109.04M | 281.40%32.35M | 409.42%33.38M | 1,069.35%23.81M | 129.43%21.73M |
| Operating expense | -17.52%41.12M | -49.45%13.79M | 40.39%12.38M | 108.89%11.45M | -56.33%3.51M | -37.42%49.85M | -40.40%27.27M | 188.95%8.82M | -31.50%5.48M | -11.29%8.03M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | -27.96%57.38M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -9.17%6.86M | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | -29.93%50.51M | ---- | ---- | ---- | ---- |
| Other operating expenses | -0.56%57.05M | -33.48%18.14M | 7.50%12.38M | 35.93%11.45M | 52.42%16.42M | --57.38M | -47.61%27.27M | 38.26%11.51M | 0.27%8.42M | -12.00%10.78M |
| Total other operating income | 111.70%15.94M | --4.35M | ---- | ---- | 370.53%12.92M | --7.53M | ---- | -48.87%2.7M | 638.94%2.94M | -14.03%2.75M |
| Operating profit | -52.03%28.4M | -61.83%1.94M | -104.05%-994K | -57.10%7.86M | 42.92%19.59M | 213.35%59.19M | 113.63%5.08M | 601.48%24.57M | 407.38%18.33M | 3,155.11%13.7M |
| Net non-operating interest income (expenses) | -29.73%-2.83M | -135.37%-1.16M | -30.86%-687K | 12.23%-488K | 18.20%-499K | 30.50%-2.18M | 30.70%-492K | 30.74%-525K | 30.76%-556K | 29.89%-610K |
| Non-operating interest expense | 29.73%2.83M | 135.37%1.16M | 30.86%687K | -12.23%488K | -18.20%499K | -30.50%2.18M | -30.70%492K | -30.74%525K | -30.76%556K | -29.89%610K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -43.05%7.53M | |||||||||
| Income before tax | -55.16%25.56M | -82.96%782K | -106.99%-1.68M | -58.50%7.38M | 45.77%19.09M | 235.27%57.01M | 112.08%4.59M | 776.13%24.04M | 362.68%17.77M | 3,016.26%13.09M |
| Income tax | -42.36%8.11M | -70.23%459K | -118.12%-739K | -45.37%2.04M | 25.15%6.35M | 389.76%14.07M | 177.29%1.54M | 341.82%4.08M | 274.17%3.74M | 57.99%5.07M |
| Net income | -59.35%17.46M | -89.40%323K | -104.72%-942K | -62.00%5.33M | 58.80%12.74M | 195.39%42.94M | 108.47%3.05M | 996.27%19.96M | 280.75%14.04M | 319.35%8.02M |
| Net income continuous operations | -59.35%17.46M | -89.40%323K | -104.72%-942K | -62.00%5.33M | 58.80%12.74M | 195.39%42.94M | 108.47%3.05M | 996.27%19.96M | 280.75%14.04M | 319.35%8.02M |
| Noncontrolling interests | 35.94%261K | -92.19%15K | 89.47%-20K | 234K | 32K | 192K | 192K | -190K | 0 | 0 |
| Net income attributable to the company | -59.77%17.2M | -89.22%308K | -104.58%-922K | -63.66%5.1M | 58.40%12.71M | 194.96%42.75M | 107.93%2.86M | 1,006.70%20.15M | 280.75%14.04M | 319.35%8.02M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -59.77%17.2M | -89.22%308K | -104.58%-922K | -63.66%5.1M | 58.40%12.71M | 194.96%42.75M | 107.93%2.86M | 1,006.70%20.15M | 280.75%14.04M | 319.35%8.02M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -46.91%0.0438 | -89.09%0.0006 | -104.62%-0.0018 | -64.34%0.0097 | 55.13%0.0242 | 194.50%0.0825 | 107.88%0.0055 | 1,014.29%0.039 | 280.13%0.0272 | 319.72%0.0156 |
| Diluted earnings per share | -50.12%0.0406 | -88.00%0.0006 | -105.00%-0.0018 | -66.54%0.0091 | 45.51%0.0227 | 193.24%0.0814 | 107.16%0.005 | 928.57%0.036 | 280.13%0.0272 | 319.72%0.0156 |
| Dividend per share | 0.00%0.01 | 0 | 0 | 0 | 0.01 | 0.01 | 0 | 0.01 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.